메뉴 건너뛰기
Journal of Hepatology
Volumn 53, Issue 3, 2010, Pages 588-
Which transarterial therapy is best for hepatocellular carcinoma? - The evidence to date
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; GELATIN SPONGE; POLYVINYL ALCOHOL;
EID: 77952374880     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.031     Document Type: Letter
Times cited : (13)
References (8)
  • 1
    • 71849107086 scopus 로고    scopus 로고
    • Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
    • T. Okusaka, H. Kasugai, Y. Shioyama, K. Tanaka, M. Kudo, and H. Saisho Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial J Hepatol 51 2009 1030 1036
    • (2009) J Hepatol , vol.51 , pp. 1030-1036
    • Okusaka, T.1    Kasugai, H.2    Shioyama, Y.3    Tanaka, K.4    Kudo, M.5    Saisho, H.6
  • 2
    • 71849111321 scopus 로고    scopus 로고
    • Transarterial therapies in HCC: Does embolization increase survival?
    • A. Forner, and J.C. Trinchet Transarterial therapies in HCC: does embolization increase survival? J Hepatol 51 2009 981 983
    • (2009) J Hepatol , vol.51 , pp. 981-983
    • Forner, A.1    Trinchet, J.C.2
  • 3
    • 33845402644 scopus 로고    scopus 로고
    • Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies
    • L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, and N. Davies Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25
    • (2007) Cardiovasc Intervent Radiol , vol.30 , pp. 6-25
    • Marelli, L.1    Stigliano, R.2    Triantos, C.3    Senzolo, M.4    Cholongitas, E.5    Davies, N.6
  • 4
    • 3042777392 scopus 로고    scopus 로고
    • Systemic treatment and liver transplantation for hepatocellular carcinoma: Two ends of the therapeutic spectrum
    • A. Burroughs, D. Hochhauser, and T. Meyer Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum Lancet Oncol 5 2004 409 418
    • (2004) Lancet Oncol , vol.5 , pp. 409-418
    • Burroughs, A.1    Hochhauser, D.2    Meyer, T.3
  • 5
    • 0028035352 scopus 로고
    • Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study
    • J.M. Chang, W.S. Tzeng, H.B. Pan, C.F. Yang, and K.H. Lai Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study Cancer 74 1994 2449 2453
    • (1994) Cancer , vol.74 , pp. 2449-2453
    • Chang, J.M.1    Tzeng, W.S.2    Pan, H.B.3    Yang, C.F.4    Lai, K.H.5
  • 6
    • 0026592922 scopus 로고
    • Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - A comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan
    • S. Kawai, J. Okamura, M. Ogawa, Y. Ohashi, M. Tani, and J. Inoue Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan Cancer Chemother Pharmacol 31 Suppl. 1992 S1 S6
    • (1992) Cancer Chemother Pharmacol , vol.31 , Issue.SUPPL.
    • Kawai, S.1    Okamura, J.2    Ogawa, M.3    Ohashi, Y.4    Tani, M.5    Inoue, J.6
  • 7
    • 0037129704 scopus 로고    scopus 로고
    • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial
    • J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, and J. Aponte Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 2002 1734 1739
    • (2002) Lancet , vol.359 , pp. 1734-1739
    • Llovet, J.M.1    Real, M.I.2    Montana, X.3    Planas, R.4    Coll, S.5    Aponte, J.6
  • 8
    • 77949264899 scopus 로고    scopus 로고
    • Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISION v study
    • doi: 10.1007/s00270-009-9711-7
    • Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol, 2009. doi: 10.1007/s00270-009-9711-7.
    • (2009) Cardiovasc Intervent Radiol
    • Lammer, J.1    Malagari, K.2    Vogl, T.3    Pilleul, F.4    Denys, A.5    Watkinson, A.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.